The Probiotics Dietary Supplement segmentation by application delineates five primary consumer categories that collectively drive market revenue. Digestive health remains the dominant segment, accounting for roughly 40โฏ% of total sales, as clinicians prescribe probiotics for irritable bowel syndrome, antibioticโassociated diarrhea, and general gut microbiome balance. Immune support follows with an estimated 30โฏ% share, reflecting growing evidence linking gut flora to systemic immune modulation and the consequent demand for prophylactic supplementation. Womenโs health, representing about 15โฏ% of the market, targets vaginal microbiota maintenance and hormoneโrelated gastrointestinal issues, prompting formulation of strains such asโฏLactobacillusโฏrhamnosusโฏGRโ1. Pediatric applications, at 10โฏ%, focus on infant colic, eczema prevention, and earlyโlife microbiome development, often leveraging strainโspecific safety data. Finally, senior health comprises the remaining 5โฏ%, addressing ageโrelated dysbiosis and nutrient absorption challenges. Each application segment contributes proportionally to the overall market size, guiding R&D investment, regulatory strategy, and distribution channels.